- Home
- SLRC vs ETRA Comparison
SLRC vs ETRA Comparison
Compare SLRC & ETRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | SLRC | ETRA |
|---|---|---|
| Founded | 2007 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 691.2M | 593.1M |
| IPO Year | 2007 | 2026 |
Fundamental Metrics
Financial Performance| Metric | SLRC | ETRA |
|---|---|---|
| Price | $11.58 | $8.40 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 6 |
| Target Price | $14.38 | ★ $33.20 |
| AVG Volume (30 Days) | ★ 395.7K | 348.3K |
| Earning Date | 11-03-2026 | 11-12-2026 |
| Dividend Yield | ★ 10.68% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.60 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.10 | N/A |
| P/E Ratio | $19.33 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.96 | $6.87 |
| 52 Week High | $16.36 | $15.14 |
Technical Indicators
Market Signals| Indicator | SLRC | ETRA |
|---|---|---|
| Relative Strength Index (RSI) | 45.96 | 44.61 |
| Support Level | $11.09 | $8.26 |
| Resistance Level | $11.61 | $9.48 |
| Average True Range (ATR) | 0.28 | 1.02 |
| MACD | 0.01 | 0.21 |
| Stochastic Oscillator | 24.40 | 51.21 |
Price Performance
Historical ComparisonAbout SLRC SLR Investment Corp.
SLR Investment Corp is a closed-end externally managed, non-diversified management investment company that has elected to be treated as a business development company. It provides U.S. middle market businesses and intermediaries with bespoke debt financing solutions to fund working capital, acquisition, refinancing and growth capital requirements. The company's investment objective is to generate both current income and capital appreciation through debt and equity investments. The company invests principally in leveraged middle-market companies in the form of senior secured loans, financing leases, and to a lesser extent, unsecured loans and equity securities.
About ETRA Electra Therapeutics Inc. Common stock
Electra Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on pioneering a new class of precision medicines for the treatment of immune-mediated diseases and cancer. The company's pipeline includes Ipsoprubart and ELA822.